Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Edwards Lifesciences Corp Completes Acquisition Of BMEYE B.V.

Wednesday, 10 Oct 2012 09:00am EDT 

Edwards Lifesciences Corp announced that it has completed the acquisition of BMEYE B.V., a privately held Dutch company that specializes in the development of non-invasive technology for advanced hemodynamic monitoring. The purchase price was EUR32.5 million (approximately $42 million). 

Company Quote

-0.1 -0.12%
28 Jul 2014